Claribel Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 Hyderabad, Telangana, India Active
Last Updated:
About Claribel Pharmaceuticals Private Limited

Claribel Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2014 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33111TG2014PTC096243. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Apsingiker Sravan Kumar (Director), Shaik Mustafa (Director), Katta Bharath Kumar (Director). Past directors included Madishetty Venkata Ramana. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2-1-290/2 Nagole, Hyderabad, Telangana, 500068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33111TG2014PTC096243

  • Registration Number

    096243

  • Incorporation Date

    05 November 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 40.26%
  • Profit Growth **** 40.35%
  • Ebitda **** 20.16%
  • Net Worth 15.81%
  • Total Assets **** 12.38%
Company report

Claribel Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Claribel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Claribel Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Apsingiker Sravan Kumar Director 05 Nov 2014 Current
Shaik Mustafa Director 05 Nov 2014 Current
Katta Bharath Kumar Director 05 Nov 2014 Current
Gandwaid Ravinder Rao Director 05 Nov 2014 Current
Ashok Manda Director 05 Nov 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Claribel Pharmaceuticals.

Claribel Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.26% increase. The company also saw a substantial improvement in profitability, with a 40.35% increase in profit. The company's net worth Soared by an impressive increase of 15.81%.

Claribel Pharmaceuticals revenue growth over time
Claribel Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
40.26%
*******
*******
*******
*******
Revenue from Operations
*******
40.24%
*******
*******
*******
*******
Total Assets
*******
12.38%
*******
*******
*******
*******
Profit or Loss
*******
40.35%
*******
*******
*******
*******
Net Worth
*******
15.81%
*******
*******
*******
*******
EBITDA
*******
20.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Claribel Pharmaceuticals?

In 2023, Claribel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Claribel Pharmaceuticals?

Unlock and access historical data on people associated with Claribel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Claribel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claribel Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Claribel Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Claribel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Claribel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Apsingiker Sravan Kumar was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was completed.

  • Director Appointment

    Progress on Shaik Mustafa was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was documented.

  • Director Appointment

    Progress on Katta Bharath Kumar was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was documented.

  • Director Appointment

    Progress on Gandwaid Ravinder Rao was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Claribel Pharmaceuticals Private Limited?

The CIN of Claribel Pharmaceuticals Private Limited is U33111TG2014PTC096243.

Where is Claribel Pharmaceuticals Private Limited headquartered?

Claribel Pharmaceuticals Private Limited is headquartered at 2-1-290/2 Nagole, Hyderabad, Telangana, 500068.

When was Claribel Pharmaceuticals Private Limited incorporated?

Claribel Pharmaceuticals Private Limited was incorporated on 05 November 2014.

Who are the current directors of Claribel Pharmaceuticals Private Limited?

The current directors of Claribel Pharmaceuticals Private Limited are

What is the primary industry of Claribel Pharmaceuticals Private Limited?

The primary industry of Claribel Pharmaceuticals Private Limited is Trade.

Is Claribel Pharmaceuticals Private Limited a listed company?

Claribel Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Claribel Pharmaceuticals Private Limited?

The authorized capital of Claribel Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Claribel Pharmaceuticals Private Limited?

The compliance status of Claribel Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available